Related Articles
REV3L, the catalytic subunit of DNA polymerase ζ, is involved in the progression and chemoresistance of esophageal squamous cell carcinoma
MicroRNA‑29a enhances cisplatin sensitivity in non‑small cell lung cancer through the regulation of REV3L
Hypersensitivity to cisplatin after hRev3 mRNA knockdown in head and neck squamous cell carcinoma cells
Increased MALAT1 expression contributes to cisplatin resistance in non‑small cell lung cancer
Impaired ζ chain expression and IFN-γ production in peripheral blood T and NK cells of patients with advanced lung cancer